|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Dova Pharmaceuticals, Inc. (DOVA) |
|
|
$28.04 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
25,652,000 |
| Market
Cap: |
719.28(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$28.04 - $28.04 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Edelman Joseph |
10% Owner |
– – • |
2019-11-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,125,851) |
0 |
|
- |
|
| Wysenski Nancy |
Director |
– • – |
2019-11-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,274) |
0 |
|
- |
|
| Novak Alfred J |
Director |
– • – |
2019-11-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,901) |
0 |
|
- |
|
| Zaccardelli David |
President & CEO |
• • – |
2019-11-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(76,647) |
0 |
|
- |
|
| Goldman Steven M. |
Director |
– • – |
2019-11-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(5,000) |
0 |
|
- |
|
| Goldman Steven M. |
Director |
– • – |
2019-11-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(144,280) |
0 |
|
- |
|
| Allen Lee F Md Phd |
Chief Medical Officer |
• – – |
2019-11-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(9,635) |
0 |
|
- |
|
| Manning Paul B |
Director |
– • • |
2019-11-12 |
4 |
D |
$27.50 |
$49,038,715 |
I/I |
(1,783,226) |
0 |
|
- |
|
| Manning Paul B |
Director |
– • • |
2019-11-12 |
4 |
D |
$27.50 |
$356,922,940 |
D/D |
(12,979,016) |
0 |
|
- |
|
| Stalfort Sean |
Director |
– • – |
2019-11-12 |
4 |
D |
$27.50 |
$17,480,788 |
D/D |
(635,665) |
0 |
|
- |
|
| Hoitt Jason |
Chief Commercial Officer |
• – – |
2019-11-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(9,970) |
0 |
|
- |
|
| Laliberte Kevin |
Sr. VP, Product Development |
• – – |
2019-11-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,761) |
0 |
|
- |
|
| Hahn Mark W |
Chief Financial Officer |
• – – |
2019-11-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(9,024) |
0 |
|
- |
|
| Jeffs Roger |
Director |
– • – |
2019-11-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(66,993) |
0 |
|
- |
|
| Zaccardelli David |
President & CEO |
• • – |
2019-10-01 |
4 |
AS |
$27.90 |
$147,173 |
D/D |
(5,275) |
76,647 |
|
- |
|
| Hoitt Jason |
Chief Commercial Officer |
• – – |
2019-09-30 |
4 |
AS |
$28.00 |
$66,836 |
D/D |
(2,387) |
9,970 |
|
- |
|
| Laliberte Kevin |
Sr. VP, Product Development |
• – – |
2019-09-30 |
4 |
AS |
$28.00 |
$103,488 |
D/D |
(3,696) |
4,761 |
|
- |
|
| Hahn Mark W |
Chief Financial Officer |
• – – |
2019-09-30 |
4 |
AS |
$28.00 |
$21,700 |
D/D |
(775) |
9,024 |
|
- |
|
| Allen Lee F Md Phd |
Chief Medical Officer |
• – – |
2019-09-30 |
4 |
AS |
$28.00 |
$27,384 |
D/D |
(978) |
9,635 |
|
- |
|
| Laliberte Kevin |
Sr. VP, Product Development |
• – – |
2019-09-25 |
4 |
AS |
$20.00 |
$62,000 |
D/D |
(3,100) |
8,457 |
|
- |
|
| Manning Paul B |
Director |
– • • |
2019-08-09 |
4 |
B |
$15.87 |
$445,344 |
D/D |
28,062 |
12,979,016 |
3.92 |
- |
|
| Laliberte Kevin |
Sr. VP, Product Development |
• – – |
2019-07-31 |
4 |
AS |
$15.97 |
$22,182 |
D/D |
(1,389) |
11,557 |
|
- |
|
| Hoitt Jason |
Chief Commercial Officer |
• – – |
2019-07-15 |
4 |
AS |
$15.10 |
$115,664 |
D/D |
(7,580) |
12,357 |
|
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2019-07-11 |
4 |
B |
$16.67 |
$715,410 |
I/I |
42,916 |
3,708,705 |
1.5 |
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2019-07-10 |
4 |
B |
$16.89 |
$208,659 |
I/I |
12,354 |
3,665,789 |
1.5 |
- |
|
91 Records found
|
|
Page 1 of 4 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
